â??Comparative Study of Efficacy of â??Shunthyadi Churnaâ?? and â??Parnasapanchaka Kwathaâ?? in the Management of Tamaka Shwasa with special reference to Bronchial Asthmaâ??.

ational Institute of Ayurved0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patient willing to give informed consent to participate for 30 days.
•2.Patients of either sex with age between 18 to 60 years.
•3.Patient with stable Bronchial Asthma (Tamaka Shwasa) (as per WHO GINA Guideline) for at least 6 weeks prior to trial.
•4.Patient presents with signs & symptoms of Tamaka Shwasa (Bronchial Asthma) as mentioned in Ayurvedic and modern texts.
•5.Symptomatic patient with positive test of reversibility (If possible).

•1.Patients with severe Bronchial Asthma.
•2.Patients present with co-morbid disorders. (D.M., T.B., R.A., Carcinoma etc.).
•3.Patients suffering from pulmonary diseases other than bronchial asthma like COPD, Pleural effusion, Pneumonia.
•4.Patients with poorly controlled Hypertension (i.e. Systolic > 160 mm of Hg and Diastolic > 100 mm of Hg)
•5.Patients with concurrent serious Hepatic disorder or Renal Disorders, severe Pulmonary Dysfunction, or any other systemic/serious complications like Cerebrovascular / Cardiovascular disease that may jeopardize the study.
•6.H/o hypersensitivity to the trial drug or any of its ingredients.
•7.Patients who have completed participation in any other clinical trial during the past six months.
•8.Pregnancy or lactating women.
•9.Any other condition which the Investigator thinks may jeopardize the study.

发起方

ational Institute of Ayurved